A point of view: The need to identify an antigen in psyconeuroimmunological disorders

Current Pharmaceutical Design

Volumn 9, Issue 24, 2003, Pages 1951-1955

  Covelli, V ^a   Pellegrino, N M ^b   Jirillo, E ^b  

^a POLICLINICO   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

AIDS dementia complex; Alzeihmer; Astrocytes; Chronic fatigue syndrome; Microglia; Migraine; Phobic disorders; Schizophrenia

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPRAZOLAM; ALZHEIMER DISEASE VACCINE; AMYLOID PRECURSOR PROTEIN; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4D; CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DIAZEPAM; ENDOTOXIN; GANGLIOSIDE GM1; INTERLEUKIN 1BETA; NEUROPEPTIDE; PROPRANOLOL; SOMATOSTATIN; THYMOPENTIN; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE; VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ANTIBACTERIAL ACTIVITY; ANTIGEN DETECTION; AUTOIMMUNITY; BACTERIAL CELL WALL; CAMPYLOBACTER JEJUNI; CELL KILLING; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CYTOKINE RELEASE; CYTOMEGALOVIRUS; ENTEROVIRUS; EPSTEIN BARR VIRUS; GRAM NEGATIVE BACTERIUM; GUILLAIN BARRE SYNDROME; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOLOGY; MENTAL DISEASE; MIGRAINE; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NERVOUS SYSTEM; NEUROLOGIC DISEASE; PHAGOCYTOSIS; PHOBIA; POLYNEUROPATHY; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SIDE EFFECT; T LYMPHOCYTE; VIRUS INFECTION;

ANTIGENS; FATIGUE SYNDROME, CHRONIC; HUMANS; MENTAL DISORDERS; NEUROIMMUNOMODULATION; PSYCHONEUROIMMUNOLOGY; RISK FACTORS;

EID: 0041677655     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033454234     Document Type: Review

References (56)

1. Stenberg EM. Nat Med 1997; 3: 264.
2. Plotinikoff NP, Faitk RE, Murgo AJ, Good RA. Cytokines Stress and Immunity CRC Press, Bola Raton 1999.
3. Merrill JE, Benveniste EN. Trends Neurosci 1996; 19: 331.
4. Delgado M, Ganza D. J Immunol 2000; 165: 114.
5. Levite M. Trends Immunol 2001; 22: 2.
6. Covelli V, Maffione AB, Munno I, Jirillo E, J Clin Lab Anal 1990; 4: 9.
7. Covelli V, Munno I, Pellegrino NM, Marcuccio C, Jirillo E. Bull Molec Biol Med 1990; 15: 99.
8. Covelli V, Massari F, Fallacara C, Munno I, Pellegrino NM, Jirillo E. et al. Int J Neurosci 1991; 61: 53.
9. Covelli V, Massari F, Fallacara C, Conrotto L, D'Andrea L, Maffione AB, et al. EOS J Immunol Immunopharmacol 1993; 13: 173.
10. Covelli V, Munno I, Altamura M, Pellegrino NM, Decandia P, Jirillo E. Immunopharmacol Immunotoxicol 1990;12: 619.
11. Covelli V, Munno I, Pellegrino NM, Marinaro MR, Gesario A, Massari F, et al. Acta Neurol 1992; 14: 313.
12. Braestrup C, Squires RF. Proc Natl Acad Sci USA 1981; 74: 503.
13. Sacerdote P, Locatelli LA, Panerai AE, Life Sci 1993; 53: 659.
14. Covelli V, Decandia P, Altamura M, Jirillo E. Immunopharmacol Immunotoxicol 1989; 11: 701.
15. Jirillo, E, Maffione AB, Greco B, Annuncio B, Calvello R, Jirillo E. Immunopharmacol Immunotoxicol 1993; 15: 307.
16. Covelli V, Maffione AB, Greco B, Cannuscio B, Calvello R, Covelli V. Immunopharmacol Immunotoxicol 1993; 15: 415.
17. Covelli V, Maffione AB, Nacci C, Tatò E, Jirillo E. Immunopharmacol Immunotoxicol 1998; 20: 199.
18. Fucjnami S, Olostone MB. Immmunol. Res., 1989; 8: 3.
19. Panitch H, Hirsch RL, Schinodler J, Johnson KP. Neurology, 1987; 37: 1097.
20. Rees JH, Soudain SE, Gregson NA, Hughes RAC. N Engl J Med 1995; 933: 1374.
21. Frendergast MM, Moran AP. J Endotoxin Res 2000; 6: 341.
22. Mastroianni CM, Paoletti F, Valenti C, Vullo V, Jirillo E, Delia S. J Neurol Neurosurg Pschiatry 1992; 11: 217.
23. Jirillo E, Covelli V, Maffione AB, Greco B, Pece S, Fumarola D. et al. Ann N Y Acad Sci 1994; 74: 174.
24. Mastroianni CM, Liuzzi GM, Jirillo E, Vullo V, Jirillo A, Delia S. et al. AIDS 1991; 5: 464.
25. Mastroianni CM, Liuzzi GM, Vullo V, Jirillo E, Delia S, Riccio P. Mol Chem Neuropathol 1991; 14: 227.
26. Liuzzi GM, Mastroianni CM, Vullo V, Jirillo E, Delia S, Riccio P. J Neuroimmunol 1992; 36: 251.
27. Covelli V, Maffione AB, Giuliani G, Pece S, Jirillo E. In Cytokines, Stress and Immunity. Plotnikoff N, Faith RE, Murgo AJ, Good RA, EOS, CRC Press Boca Raton 1998, pp. 61-68.
28. Selkoe DJ. Science 1990; 248: 1058.
29. Abraham CR, Selkoe DJ, Potter H. Cell 1988; 52: 487.
30. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD. et al. Proc Natl Acad Sci USA 1992; 89: 10016.
31. Straub RH, Schedlowski M. Trends Immunol 2002; 23: 118.
32. Bachmann MF Trends Immunol 2002; 23: 569.
33. Levine PH. EOS J Immunol Immunopharmacol 1995; 15: 4.
34. Tobi M, Morag A, Ravid Z, Chokers I, Feldmann-Weiss V, Michaeli Y. et al. Lancet 1982; 1: 61.
35. Straus SE, Tosato G, Armstrong G, Lawley T, Proble OT, Henle W. et al. Ann Intern Med 1985; 102: 7.
36. Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas D. Ann Intern Med 1985; 102: 1.
37. Jones JF. EOS J Immunol Immunopharmacol 1995; 15: 20.
38. Tan EM, Sugiura K, Gupta S. J Clin Immunol 2002; 22: 8.
39. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE. et al. Ann Intern Med 1988; 108: 387.
40. Majeed T, Behan PO. EOS J Immunol Immunopharmacol 1995; 15: 8.
41. Man P. Am J Med 2000; 108: 172.
42. DeMeirleir K, Bisbal C, Campine I, De Becker P, Salehzada T, Demettre E. et al. Am J Med 2000; 108: 99.
43. Demettre E, Bastide L, D'Haese A, De Smet K, De Meirleir K, Tiev KP. et al. J Biol Chem 2002; 277: 35746.
44. Buchwald D, Komaroff AL, EOS J Immunol Immuno-pharmacol 1995; 15: 15.
45. Whiteside TL, Friberg D. Am J Med 1998; 105: 275.
46. Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, et al. J Clin Endocrinol Metab 1991; 73: 1224.
47. Brandtzaeg P, Baekkevold ES, Farstad IN, Jamnsen FL, Johansen FE, Nilsen EM. et al. Immunol Today 1999; 20: 141.
48. Sartor RB. Curr Opin Gastroenterol 2001; 17: 553.
49. Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D. J Endotoxin Res 2002; 6: 205.
50. Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D. Am J Gastroenterol 2000; 95: 1495.
51. Caradonna L, Mastronardi ML, Magrone T, Cozzolongo R, Cuppone R, Manghisi OG. et al. Curr Pharm Design 2002; 8: 995.
52. Jirillo E, Caccavo D, Magrone T, Piccigallo E, Amati L, Lembo A. et al. J Endotoxin Res 2002; 8: 319.
53. Amati L, Caradonna I, Leandro G, Magrone T, Minenna M, Faleo G. et al. Curr Pharm Design 2003; in press.
54. Ito C. Analysis of overall gene expression induced by amphetamine and phencyclidine: novel targets for the treatment of drug psychosis and schizophrenia. Curr Pharm Des 2002; 8(2): 147-53.
55. Salerno L, Sorrenti V, Di Giacomo C, Romeo G, Siracusa MA. Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr Pharm Des 2002; 8(3): 177-200.
56. Schechter LE, Dawson LA, Harder JA. The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer's disease. Curr Pharm Des 2002; 8(2): 139-45.